21 Feb 2017 | 11:02 AM
 

Alembic Pharmaceuticals Ltd. Share Price Live (BSE)
0

BSE Code: 533573 | NSE Symbol: APLLTD
583.15
0.56
(0.10 %)
21 Feb 2017 | 10:56 AM
Change company
  • Open (Rs)
    575.00
  • Prev. close (Rs.)
    582.60
  • High (Rs.)
    589.50
  • Low (Rs.)
    575.00
  • 52W H (Rs.)
    699.50
  • 52W L (Rs.)
    515.55
  • Volume (Rs.)
    2828
  • MCap (Rs in Cr.)
    10,993.32
0
0.00
(0.00 %)
  • Open (Rs)
    0.00
  • High (Rs)
    0.00
  • Low (Rs)
    0.00
  • Prev. close(Rs)
    0.00
  • Contracts Tra.
  • Turnover (Cr.)
    N.A.
  • Open Interest
  • Open Int. chg
    0.00
1D| 1W| 1M | 3M | 6M | 1YR | MAX

Financials

EPS
38.16
Operating Margin (%)
31.94
Gross Profit Margin (%)
29.65
Net Profit Margin (%)
22.84
Total Debt/Equity
0.08
Dividend payout Ratio (Net Profit)
0.00
Earning Retention Ratio
100.00

News

16 Dec 2016 - 12:01:00-Alembic Pharmaceuticals said that it has received approval from the US Food & Drug Administration (U...
05 Dec 2016 - 10:51:00-Drug maker Alembic Pharmaceuticals Ltd said that it has received approval from the US health regulat...
05 Oct 2016 - 12:01:00-Drug maker Alembic Pharmaceuticals said that it has received the Establishment Inspection Report fro...
05 Oct 2016 - 11:45:00-Shares of Alembic Pharmaceuticals rose nearly 6 per cent on the Bombay Stock Exchange after the drug...

Announcements

09-Feb-2017
Alembic Pharmaceutic - Newspaper advertisement for postal ballot notice
01-Feb-2017
Alembic Pharmaceutic - Notice of Postal Ballot
25-Jan-2017
Alembic Pharmaceutic - Announces Q3 results (Standalone & Consolidated) Limited Review Report (Standalone & Consolidated) R
17-Jan-2017
Alembic Pharmaceutic - Schedule of Post Results Conference Call
13-Jan-2017
Alembic Pharmaceutic - Reclassification of Shares

Religare Research

21 Feb 2017 | 07:00 AM
We suggest maintaining positive yet cautious approach in index, considering the overbought market co...
20 Feb 2017 | 07:39 PM
Gold prices fell on Friday as the stronger dollar outweighed concerns about uncertainty surrounding ...
20 Feb 2017 | 06:00 PM
Tech Stars, comprises our 2 top stock picks filtered on the basis of momentum from our coverage univ...
20 Feb 2017 | 02:48 PM
Talwalkars Better Value Fitness Ltd (TBVFL) reported in-line numbers for Q3FY17 with a revenue and P...

Fund Interest

Schemes Shares Held Mkt. Value Latest Nav % Nav
6,09,449 43.57 15.76 0.25
6,09,449 43.57 29.60 0.27
6,09,449 43.57 31.00 0.29
6,09,449 43.57 18.74 0.32
6,09,449 43.57 11.72 0.26

Shareholding Pattern

       
Promotors72.68%
Mutual Funds/UTI2.63%
FI/Banks0.32%
Insurance0.32%
FII10.68%
Government0.00%
Others2.13%

Peer Group

Company Intraday Graph
 Dr. Reddy`s Laboratories Ltd.
2,903.95(0.01)
3294
 GlaxoSmithKline Pharmaceuticals Ltd.
2,686.00(0.18)
3317
 Alkem Laboratories Ltd.
2,033.20(-0.29)
17141
 Piramal Enterprises Ltd.
1,894.50(0.15)
3356

Exchange Information

NSE Index
Sensex
CNX 100
BSENAT
CNX 200
BSE200
CNX Bank
BSE500
CNX500
BSE Midcap
CNX Midcap
BSE Smallcap
Note: The scrip is a constituent of those NSE and BSE indices that have against them.

Company Indices

 1M (%)3M (%)6M (%)
Alembic Pharmaceuticals Ltd.-10.70-26.90-59.35
NIFTY(S&P CNX)522.65942.90242.85
BSE SENSEX1,587.182,856.54636.14
BSE 500776.121,473.63531.02

Corporate Details

Key Personal
Chirayu Amin
Executive Chairman & CEO
Pranav Amin
Managing Director
R K Baheti
Director - Finance & CFO
Key Address
Registered Office
Alembic Road,Vadodra,Gujarat

Tel:0265-2280550, Fax:0265-2282506

apl.investors@alembic.co.in
http://www.alembic-india.com
Registrar Office
Link Intime India Pvt. Ltd.
Add. :C-13 Pannalal Silk Mill Compound LBS Marg Bhandup (West)

Make smart investment decisions with Star Ratings, a stock selection tool, based upon fundamental, technical and analyst recommendations. Star Ratings provides stock trading tips for Alembic Pharmaceuticals Ltd. that will help you decide whether to buy, sell or hold Alembic Pharmaceuticals Ltd. It also provides you with switch proposals on alternative stocks, i.e., which stocks to buy against Alembic Pharmaceuticals Ltd.